Advanced Tissue Sciences Inc Sample Contracts

AutoNDA by SimpleDocs
BETWEEN
License Agreement • March 28th, 2001 • Advanced Tissue Sciences Inc • Biological products, (no disgnostic substances) • California
ADVANCED TISSUE SCIENCES, INC. COMMON STOCK, PAR VALUE $.01 PER SHARE ------------ UNDERWRITING AGREEMENT
Underwriting Agreement • February 23rd, 1996 • Advanced Tissue Sciences Inc • Biological products, (no disgnostic substances) • New York
1 EXHIBIT 1.1 Draft of March 14, 1996 ADVANCED TISSUE SCIENCES, INC. COMMON STOCK, PAR VALUE $.01 PER SHARE UNDERWRITING AGREEMENT
Underwriting Agreement • March 19th, 1996 • Advanced Tissue Sciences Inc • Biological products, (no disgnostic substances) • New York
COMMON STOCK
Common Stock Purchase Agreement • March 28th, 2001 • Advanced Tissue Sciences Inc • Biological products, (no disgnostic substances) • California
WITNESSETH:
Supply Agreement • March 28th, 2001 • Advanced Tissue Sciences Inc • Biological products, (no disgnostic substances) • New Jersey
RECITALS:
Investment Agreement • March 29th, 2002 • Advanced Tissue Sciences Inc • Biological products, (no disgnostic substances) • Delaware
UBS Warburg UBS Warburg LLC 299 Park Avenue New York, NY 10171-0026 Telephone: 212 821-4000 www.ubswarburg.com
Placement Agent Agreement • February 8th, 2002 • Advanced Tissue Sciences Inc • Biological products, (no disgnostic substances) • New York
LEASE
Lease Agreement • March 29th, 2002 • Advanced Tissue Sciences Inc • Biological products, (no disgnostic substances) • California
LICENSE AGREEMENT
License Agreement • March 29th, 2002 • Advanced Tissue Sciences Inc • Biological products, (no disgnostic substances) • Delaware
EXHIBIT I Agreement of Joint Filing Pursuant to Rule 13d-1(k)(1)(iii) of Regulation 13D-G of the General Rules and Regulations of the Securities and Exchange Commission under the Securities Exchange Act of 1934, as amended, the undersigned agree that...
Joint Filing Agreement • October 15th, 2002 • Advanced Tissue Sciences Inc • Biological products, (no disgnostic substances)

Pursuant to Rule 13d-1(k)(1)(iii) of Regulation 13D-G of the General Rules and Regulations of the Securities and Exchange Commission under the Securities Exchange Act of 1934, as amended, the undersigned agree that the statement to which this exhibit is attached is filed on behalf of each of them in the capacities set forth below.

RECITALS
Loan and Security Agreement • October 15th, 2002 • Advanced Tissue Sciences Inc • Biological products, (no disgnostic substances) • Delaware
FORM OF ADDENDUM TO STOCK OPTION AGREEMENT
Stock Option Agreement • October 1st, 1997 • Advanced Tissue Sciences Inc • Biological products, (no disgnostic substances)
AutoNDA by SimpleDocs
1.1 Lease of Property 6
Build-to-Suit Lease • March 30th, 1998 • Advanced Tissue Sciences Inc • Biological products, (no disgnostic substances) • California
Exhibit 4.1 Proprietary and Confidential INVESTMENT AGREEMENT
Investment Agreement • February 20th, 1996 • Advanced Tissue Sciences Inc • Biological products, (no disgnostic substances) • New York
ADDENDUM TO LICENSE AGREEMENT BETWEEN
License Agreement • March 28th, 2001 • Advanced Tissue Sciences Inc • Biological products, (no disgnostic substances)
LOAN AGREEMENT for a U.S. $16,000,000 LOAN FACILITY
Loan Agreement • November 12th, 1997 • Advanced Tissue Sciences Inc • Biological products, (no disgnostic substances)
RECITALS
Joint Venture Agreement • January 27th, 1998 • Advanced Tissue Sciences Inc • Biological products, (no disgnostic substances) • Delaware
EXHIBIT XII ASSET AND EQUITY PURCHASE AGREEMENT Dated as of October 10, 2002
Asset and Equity Purchase Agreement • October 15th, 2002 • Advanced Tissue Sciences Inc • Biological products, (no disgnostic substances) • Delaware
Draft better contracts in just 5 minutes Get the weekly Law Insider newsletter packed with expert videos, webinars, ebooks, and more!